1955 Wroblewski et al., Proc. Soc. Exp. Biol. Med. 90:210-213. |
1964 Black et al., Exp. Cell Research 35:9-13. |
1970 Oldendorf, Brain Res. 24:37-46. |
1971 Oldendorf, Am. J. Physiol. 221:1629-1638. |
1975 Fonnum, J. Neurochem. 24:407-409. |
1976 Kolbe et al., Biochemistry & Biophysics 73:378-382. |
1976 Keller et al., Archives of Pharmacology 294:213-215. |
1977 Perez-Polo et al., Life Sci. 21:1535-1543. |
1980 Luine et al., Brain Research 191:273-277. |
1982 Barde et al., EMBO J. 1:549-553. |
1984 Fallon et al., Science 224:1107-1109. |
1986 Morrison et al., Prc. Nat'l. Acad. Sci. U.S.A. 83:7537-7541. |
1986 Morse et al., Experimental Neurology 94:649-658. |
1986 Aizenman et al., Proc. Nat'l. Acad. Sci. U.S.A. 83:2263-2266. |
1986 Fillet et al., Psychoneuroendocrinology 11:337-345. |
1987 Morrison et al., Science 238:72-75. |
1987 Monard, Biochem. Pharmacol. 36:1389-1392. |
1987 Thoenen et al., Rev. Physiol. Biochem. Pharmacol. 109:145-178. |
1987 Whittemore et al., J. Neurosci. 7:244-251. |
1987 Baskin et al., Ann. Rev. Physiol. 49:335-347. |
1988 Derynck, Cell 54:161-170. |
1988 Rosenberg et al., Science 242:1575-1578. |
1988 Walicke, J. Neurosci. 8:2618-2627. |
1988 Mouton et al., Brain Research 444:104-108. |
1989 Stockli et al., Nature 342:920-923. |
1989 Yamamori et al., Science 246:1412-1416. |
1989 Oltersdorf et al., Nature 341:144-147. |
1989 Whitson et al., Science 243:1488-1490. |
1989 Hama et al., Neurosci. Lett. 104:340-344. |
1989 Hefti et al., Neurobiol. Aging 10:515-533. |
1989 Lin et al., Science 246:1023-1025. |
1989 Honjo et al., Steroid Biochemistry 34:521-524. |
1989 Gall et al., Science 245:758-761. |
1990 Kovesdi et al., Biochem. Biophys. Res. Commun. 172:850-854. |
1990 Kamegai, Neuron 2:429-436. |
1990 Hohn et al., Nature 344:339-341. |
1990 Fallon et al., Growth Factors 2:241-250. |
1990 Spranger et al., Eur. J. Neurosci. 2:69-76. |
1990 Maisonpierre et al., Neuron 5:501-509. |
1990 Ernfors et al., Neuron 5:511-526. |
1990 Rosenthal et al., Neuron 4:767-773. |
1991 Hallbrook et al., Neuron 6:845-858. |
1991 Berkemeier et al., Neuron 7:857-866. |
1992 Woolley et al. Journal of Neuroscience 12:2549-2554. |
1993 Gibbs et al., Society for Neuroscience Abstracts 19:5. |
1987 Wright et al., Int. J. Dev. Neuroscience 5:305-311. |
1988 Jones, Metabolic Brain Disease 3:1-18. |
1992 Mizoguchi et al., Neuroscience Letters 138:157-160. |
1992 Honjo et al., J. Steroid Biochem. Molec. Biol. 41:633-635. |
1993 Emerson et al., Brain Research 608:95-100. |
1996 Draper, Michael W., et al, "A Controlled Trial of Raloxifene (LY139481) HCI: Impact on Bone Turnover and Serum Lipid Profile in Healthy Postmenopausal Women", Journal of bone and Mineral Research; vol. 11. |
1994 Evans, Glenda, et al, "The Effects of Raloxifene on Tibia Histomorphometry in Ovariectomized Rats", Endocrinology; 1345-2283. |
1994 Sato, Masahiko, et al, "Dual-Energy X-ray Absorpitiometry of Raloxifene Effects on the Lumbar Vertebrae and Femora of Ovariectomized Rats", Journal of Bone and Mineral Research, vol. 9, No. 5. |
1995 Sato, Masahiko, et al, "Longitudinal and Cross-Section Analysis of Raloxifene Effect on Tibiae from Ovariectomized Aged Rats", The Journal of Pharmacology and Experimental Therapeutics, 272:1252-1259. |
Chemical Abstracts (115:214850) Miura et al. (1991) See the Enclosed Abstract. |